Alur Orthopedic Implants
Alur Orthopedic Implants
The global orthopedic market has witnessed a paradigm shift in the treatment of femoral fractures. Femoral Intramedullary Nails (IMN) have emerged as the "Gold Standard" for internal fixation of long bone fractures. As a leading manufacturer in China, we understand that the rise in geriatric populations worldwide has led to an increase in trochanteric and femoral neck fractures, necessitating highly advanced and reliable IMN systems.
Currently, the market is moving towards minimally invasive surgery (MIS) and specialized nail designs that cater to specific anatomical variations. Our production facility integrates AI-driven manufacturing processes to ensure each nail provides optimal biomechanical stability, facilitating early weight-bearing and accelerated patient rehabilitation.
Transitioning from traditional stainless steel to high-strength Grade 5 Titanium Alloys (Ti6Al4V). This provides better biocompatibility and reduced MRI interference, matching the modulus of elasticity closer to human bone.
Modern nails feature a pre-curved design and varied distal locking options to accommodate the natural curvature of the femur, reducing the risk of cortical penetration during insertion.
The development of carbon-fiber targeting devices and radiolucent instruments allows surgeons better visibility under C-arm guidance, ensuring pinpoint accuracy in locking screw placement.
As a prominent China Femoral Intramedullary Nails Manufacturer, we offer a unique blend of "High Quality" and "Cost Efficiency." Our strategy is built on the pillars of "Blue Ocean, Differentiation, and Focus Strategy."
The company places great importance on scientific and technological innovation. Its product development strategy follows the principles of "blue ocean, differentiation, and focus strategy," with a strong emphasis on limb orthopedics, pediatric orthopedics, and internal and external fixation products for foot and ankle surgery. The company has obtained 27 national utility model patent certificates, 6 invention patents, and 2 software copyrights.
With a production capacity covering more than 8,000 product specifications in orthopedic trauma, spinal implants, and surgical instruments, the company has gradually established competitive advantages in research and development, production and manufacturing, quality control, marketing, and other key areas. The marketing team consists of more than 40 professionals, with sales and technical service personnel present in over 20 major cities. We have built a nationwide marketing network covering 31 provinces and cities, collaborating with more than 300 agents and serving over 300 top-tier teaching hospitals.
Designed for rapid deployment in emergency trauma centers, our IMN systems feature simplified instrument sets for faster surgical turnaround times in high-traffic hospitals.
Optimized for osteoporotic bone, our PFNA (Proximal Femoral Nail Antirotation) systems provide superior cut-out resistance through helical blade technology.
Our export business covers Brazil, Colombia, Peru, Egypt, and Morocco, providing tailored logistics and technical training for local distributors.
Purchasing departments of international hospitals and medical device distributors require more than just a product; they require a partnership. Our company actively engages in academic promotion, technical services, and product training, participating in or hosting more than 50 academic conferences for orthopedic doctors annually. This commitment ensures that our Femoral Intramedullary Nails are used with the highest level of clinical proficiency.
Our self-operated export business is robustly structured to handle the complexities of international trade. We offer:
